Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gore

Showing results (531-540 of 6,138) with videos related to

Pageof 614
Sort By:
Expert Opinion on Emerging Drugs|August 9, 2005
Emerging drugs for the treatment of myelodysplastic syndromePhilip J Nivatpumin, Steven D Gore
Drugs|March 1, 1991
Cardiovascular therapies in the 1990s. An overviewR C Becker, J M Gore
World Journal of Urology|November 21, 2008
Quality of care in bladder cancer: trends in urinary diversion following radical cystectomyJohn L Gore, Mark S Litwin,
Current Cardiology Reports|July 1, 2009
Cardiovascular disease and type 2 diabetes mellitus: regulating glucose and regulating drugsM Odette Gore, Darren K McGuire
Virology|November 11, 2008
The BDLF2 protein of Epstein-Barr virus is a type II glycosylated envelope protein whose processing is dependent on coexpression with the BMRF2 proteinMindy Gore, Lindsey M Hutt-Fletcher
Journal of Water and Health|April 9, 2010
Too much or too little? A review of the conundrum of seleniumFiona Gore, John Fawell, Jamie Bartram
Insect Molecular Biology|September 18, 2009
RNA interference-mediated knock-down of Bla g 1 in the German cockroach, Blattella germanica L., implicates this allergen-encoding gene in digestion and nutrient absorptionA Suazo, C Gore, C Schal
Infection and Immunity|August 18, 2010
CsrA and Cra influence Shigella flexneri pathogenesisAja L Gore, Shelley M Payne
Occupational and Environmental Medicine|November 13, 2010
The two-stage clonal expansion model in occupational cancer epidemiology: results from three cohort studiesAriana Zeka, Rebecca Gore, David Kriebel
The Journal of Surgical Research|March 1, 1996
In vivo metabolic response of glucose to dichloroacetate in humansJ A Brown, D C Gore
Pageof 614

Showing results (531-540 of 6,138) with videos related to

Sort By:
Pageof 614
Expert Opinion on Emerging Drugs|August 9, 2005
Emerging drugs for the treatment of myelodysplastic syndromePhilip J Nivatpumin, Steven D Gore
Drugs|March 1, 1991
Cardiovascular therapies in the 1990s. An overviewR C Becker, J M Gore
World Journal of Urology|November 21, 2008
Quality of care in bladder cancer: trends in urinary diversion following radical cystectomyJohn L Gore, Mark S Litwin,
Current Cardiology Reports|July 1, 2009
Cardiovascular disease and type 2 diabetes mellitus: regulating glucose and regulating drugsM Odette Gore, Darren K McGuire
Virology|November 11, 2008
The BDLF2 protein of Epstein-Barr virus is a type II glycosylated envelope protein whose processing is dependent on coexpression with the BMRF2 proteinMindy Gore, Lindsey M Hutt-Fletcher
Journal of Water and Health|April 9, 2010
Too much or too little? A review of the conundrum of seleniumFiona Gore, John Fawell, Jamie Bartram
Insect Molecular Biology|September 18, 2009
RNA interference-mediated knock-down of Bla g 1 in the German cockroach, Blattella germanica L., implicates this allergen-encoding gene in digestion and nutrient absorptionA Suazo, C Gore, C Schal
Infection and Immunity|August 18, 2010
CsrA and Cra influence Shigella flexneri pathogenesisAja L Gore, Shelley M Payne
Occupational and Environmental Medicine|November 13, 2010
The two-stage clonal expansion model in occupational cancer epidemiology: results from three cohort studiesAriana Zeka, Rebecca Gore, David Kriebel
The Journal of Surgical Research|March 1, 1996
In vivo metabolic response of glucose to dichloroacetate in humansJ A Brown, D C Gore
Pageof 614